← FDA Drug Approvals (Drugs@FDA)

RHUZDAH

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2022-10-11

Drug application

FDA Application #

ANDA207585

Application type

Abbreviated New Drug Application (Generic)

Brand name

RHUZDAH

Generic name

NORETHINDRONE AND ETHINYL ESTRADIOL TABLET

Active ingredients

ETHINYL ESTRADIOL; NORETHINDRONE

Dosage form

TABLET

Route

ORAL-28

Marketing status

Discontinued

Sponsor

AUROBINDO PHARMA

Manufacturer

Aurobindo Pharma Limited

First approval

2022-10-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown